| infectious disease | Q18123741 |
| class of disease | Q112193867 |
| pneumococcal infection | Q4366062 |
| bacterial meningitis | Q3678510 |
| infectious disease with epilepsy | Q55785635 |
| P268 | Bibliothèque nationale de France ID | 120072716 |
| P508 | BNCF Thesaurus ID | 58009 |
| P11956 | Experimental Factor Ontology ID | 1001114 |
| P2671 | Google Knowledge Graph ID | /g/1216fr51 |
| P494 | ICD-10 ID | G00.1 |
| P4229 | ICD-10-CM | G00.1 |
| P493 | ICD-9 ID | 320.1 |
| P1692 | ICD-9-CM | 320.1 |
| P3827 | JSTOR topic ID (archived) | pneumococcal-meningitis |
| P3201 | Medical Dictionary for Regulatory Activities ID | 10035645 |
| 10035645 | ||
| P486 | MeSH descriptor ID | D008586 |
| P672 | MeSH tree code | C01.150.252.223.500.875 |
| C01.150.252.410.890.670.595 | ||
| C01.207.180.500.875 | ||
| C10.228.228.180.500.875 | ||
| C10.586.625.280.560 | ||
| P5270 | Mondo ID | MONDO_0006913 |
| P1368 | National Library of Latvia ID | 000332841 |
| P1550 | Orphanet ID | 55655 |
| P2892 | UMLS CUI | C0025295 |
| P1995 | health specialty | neurology | Q83042 |
| infectious diseases | Q788926 | ||
| P5008 | on focus list of Wikimedia project | WikiProject Medicine | Q4099686 |
| Q59333982 | 327. Comparison of Clinical Outcome, Causative Serotypes, and Antimicrobial Susceptibilities Between Pneumococcal Meningitis and Pneumococcal Bacteremic Pneumonia in Adult Patients in the Republic of Korea |
| Q59327281 | 632. Recurrent Pneumococcal Meningitis in Adults |
| Q38525885 | A CASE OF PNEUMOCOCCAL MENINGITIS WITH SPINAL EOSINOPHILIA |
| Q40546922 | A case of acute pneumococcal meningitis treated with spinal drainage and vancomycin administration |
| Q71676044 | A case of penicillin-resistant pneumococcal meningitis |
| Q44695255 | A case of penicillin-resistant pneumococcal meningitis and antibiotic susceptibility of Streptococcus pneumoniae isolated from children |
| Q83225277 | A case of pneumococcal meningitis |
| Q47965219 | A case of pneumococcal meningitis associated with chronic mastoid infection and complicated by malaria |
| Q79587331 | A case of pneumococcal meningitis following a head injury |
| Q75648569 | A case of pneumococcal meningitis successfully treated |
| Q82100684 | A case of pneumococcal meningitis successfully treated with penicillin |
| Q83300498 | A case of pneumococcal meningitis with recovery |
| Q83320891 | A case of pneumococcal meningitis with recovery |
| Q75943730 | A case of primary pneumococcal meningitis with recovery |
| Q83208325 | A case of suspected pneumococcal meningitis |
| Q84767848 | A clear CSF is not always a normal CSF: a case report of pneumococcal meningitis |
| Q60213087 | A kinetic study of the cytokine/chemokines levels and disruption of blood-brain barrier in infant rats after pneumococcal meningitis |
| Q40207528 | A pediatric case of pneumococcal meningitis due to Streptococcus pneumoniae serotype 35F |
| Q42726916 | A polymerase chain reaction-enzyme immunoassay for diagnosis of pneumococcal meningitis in children and adults |
| Q35282963 | A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis |
| Q77805858 | A possible secondary case of pneumococcal meningitis |
| Q72477988 | A rare case of permanent relapse of pneumococcal meningitis |
| Q40623633 | A retrospective clinical study on pneumococcal meningitis in 0- to 1-year-old infants hospitalized in 1987-1996 in the Infectious Disease Clinic, Iaşi |
| Q40560676 | A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults |
| Q37187296 | A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis |
| Q35557427 | A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs |
| Q71161519 | A study of cephalothin and desacetylcephalothin in cerebrospinal fluid in therapy for experimental pneumococcal meningitis |
| Q68399423 | A suggested vaccine formulation for the control of pneumococcal meningitis in Egypt |
| Q33328986 | A survival case of fulminant pneumococcal meningitis as overwhelming postsplenectomy infection (OPSI) syndrome |
| Q74772554 | ACTH and adrenal steroids in the treatment of pneumococcal meningitis in adults |
| Q91133089 | AN AUDIT OF ADJUNCTIVE STEROID USE FOR PNEUMOCOCCAL MENINGITIS AT A TERTIARY HOSPITAL IN SYDNEY, AUSTRALIA FROM 2005 TO 2015 |
| Q40689621 | ANOTHER RECOVERY FROM PNEUMOCOCCAL MENINGITIS |
| Q71568178 | Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis |
| Q70680717 | Acute endocarditis following pneumococcal meningitis |
| Q48308261 | Acute epidural abscess complicating pneumococcal meningitis in adult |
| Q46556303 | Acute pneumococcal meningitis 3 1/2 years after skull base fracture |
| Q27349787 | Adjunctive dexamethasone affects the expression of genes related to inflammation, neurogenesis and apoptosis in infant rat pneumococcal meningitis |
| Q103729327 | Adjuvant Cannabinoid Receptor Type 2 Agonist Modulates the Polarization of Microglia Towards a Non-Inflammatory Phenotype in Experimental Pneumococcal Meningitis |
| Q33281825 | Adjuvant TACE inhibitor treatment improves the outcome of TLR2-/- mice with experimental pneumococcal meningitis |
| Q33547703 | Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis |
| Q53830614 | Adjuvant non-bacteriolytic and anti-inflammatory combination therapy in pneumococcal meningitis: an investigation in a mouse model. |
| Q41052838 | Adjuvant treatment with dexamethasone plus anti-C5 antibodies improves outcome of experimental pneumococcal meningitis: a randomized controlled trial |
| Q49693480 | Adult Patients with Pneumococcal Meningitis at a Neurosurgical Neurologic Center: Different Predisposing Conditions? |
| Q37566646 | Adult pneumococcal meningitis presenting with normocellular cerebrospinal fluid: two case reports |
| Q40579454 | Adult pneumococcal meningitis with no inflammatory cells in the CSF. |
| Q34031922 | An adult case of pneumocephalus and pneumococcal meningitis associated with the sphenoid sinusitis |
| Q36166629 | An outbreak of pneumococcal meningitis among older children (≥5 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana. |
| Q46097024 | Analysis of delayed cerebrospinal fluid sterilization of pneumococcal meningitis in children |
| Q72704763 | Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis |
| Q71106297 | Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis |
| Q67883887 | Antibiotic resistance to pneumococcal meningitis |
| Q41110104 | Antibiotic treatment of pneumococcal meningitis (author's transl) |
| Q39930359 | Antibody-induced neutrophil depletion prior to the onset of pneumococcal meningitis influences long-term neurological complications in mice. |
| Q44209453 | Antimicrobial therapy in pneumococcal meningitis: an epidemiological assessment from Turkey |
| Q45230516 | Antioxidant treatment prevents cognitive impairment and oxidative damage in pneumococcal meningitis survivor rats |
| Q48400911 | Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats |
| Q88914866 | Antiphospholipid Syndrome Complicating Pneumococcal Meningitis |
| Q27316800 | Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis |
| Q51198315 | Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models. |
| Q50509362 | Assessment of cochlear damage after pneumococcal meningitis using otoacoustic emissions. |
| Q71008491 | Association between persistence of pneumococcal meningitis and dexamethasone administration |
| Q92734579 | Association of Pneumococcal Conjugate Vaccine Coverage With Pneumococcal Meningitis: An Analysis of French Administrative Areas, 2001-2016 |
| Q92903820 | Association of toll-like receptor 10 polymorphisms with pediatric pneumococcal meningitis |
| Q33260257 | Attenuated cerebrospinal fluid leukocyte count and sepsis in adults with pneumococcal meningitis: a prospective cohort study |
| Q33676211 | Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis |
| Q38898248 | Austrian's syndrome: The first described case of pneumococcal meningitis pneumonia and endocarditis in an injecting drug user |
| Q38736046 | Autosplenectomy Causing Catastrophic Pneumococcal Meningitis in a Patient with Lupus/Antiphospholipid Antibody Syndrome |
| Q68200378 | Autosplenectomy Complicating Pneumococcal Meningitis in Adults |
| Q70145906 | Autosplenectomy complicating pneumococcal meningitis in an adult |
| Q48484981 | B7-H3 participates in the development of experimental pneumococcal meningitis by augmentation of the inflammatory response via a TLR2-dependent mechanism |
| Q33669578 | Bacteremia causes hippocampal apoptosis in experimental pneumococcal meningitis |
| Q30449424 | Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits |
| Q96606956 | Bilateral intracranial stenting for refractory post-infectious cerebral vasculitis secondary to Pneumococcal Meningitis |
| Q72971550 | Bilateral renal cortex necrosis associated with a Sanarelli-Shwartzman phenomenon following pneumococcal meningitis with chronic essential erythroblastopenia (so-called Blackfan-Diamond anemia) |
| Q59791877 | Blood‒Brain Barrier Pathology and CNS Outcomes in Meningitis |
| Q41279114 | Brain abscesses complicating acute pneumococcal meningitis during etanercept therapy |
| Q58549950 | Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG and Pluronic P85 unimers |
| Q98394500 | Brains, bacteria and behaviors: the role of interferon-gamma in the pathogenesis of pneumococcal meningitis |
| Q83993308 | Breakthrough pneumococcal meningitis in a patient treated with pristinamycin |
| Q28742681 | Burden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: a systematic literature review |
| Q35348131 | C-reactive protein: a valuable acute investigation. A case of pneumococcal meningitis presenting as ankle pain. |
| Q48151167 | C1 inhibitor treatment improves host defense in pneumococcal meningitis in rats and mice |
| Q35604159 | CCAAT/enhancer-binding protein δ (C/EBPδ) aggravates inflammation and bacterial dissemination during pneumococcal meningitis |
| Q76931577 | CEREBROSPINAL FLUID RHINORRHEA IN THE ETIOLOGY OF RECURRENT PNEUMOCOCCAL MENINGITIS |
| Q69611047 | CSF exchange after the erroneous intrathecal injection of 800 mg ceftriaxone for pneumococcal meningitis |
| Q46176815 | Can infant vaccination prevent pneumococcal meningitis outbreaks in sub-Saharan Africa? |
| Q63866056 | Can pneumococcal meningitis surveillance be used to assess the impact of pneumococcal conjugate vaccine on total invasive pneumococcal disease? A case-study from South Africa, 2005–2016 |
| Q79913758 | Capture-recapture analysis and pneumococcal meningitis estimates in England |
| Q92452223 | Case Commentary: Delayed Cerebral Vasculitis Associated with the Development of Ceftriaxone-Resistant Pneumococcal Meningitis |
| Q71004146 | Case report: penicillin-resistant pneumococcal meningitis: navigating a therapeutic minefield |
| Q38784137 | Case-control study shows that neonatal pneumococcal meningitis cannot be distinguished from group B Streptococcus cases |
| Q91451537 | Catastrophic cerebral hemorrhage and edema in a patient with pneumococcal meningitis |
| Q71658293 | Cefotaxime failure in pneumococcal meningitis caused by a susceptible isolate |
| Q90724951 | Central Diabetes Insipidus in an Infant with Pneumococcal Meningitis |
| Q79750686 | Central nervous system vasculitis following pneumococcal meningitis |
| Q73836602 | Cerebellar involvement as a rare complication of pneumococcal meningitis |
| Q61708429 | Cerebral Output of Cytokines in Patients with Pneumococcal Meningitis |
| Q91523110 | Cerebral Vasculitis Complicating Pneumococcal Meningitis |
| Q83362213 | Cerebral arteritis and phlebitis in pneumococcal meningitis |
| Q83865453 | Cerebral ischaemia in the context of improving, steroid-treated pneumococcal meningitis |
| Q71856595 | Cerebrospinal fluid filtration in a case of severe pneumococcal meningitis |
| Q68755521 | Cerebrospinal fluid levels of ampicillin and penicillin during pneumococcal meningitis: experimental studies in dogs |
| Q70404981 | Cerebrospinal fluid prognostic indices in experimental pneumococcal meningitis |
| Q45229635 | Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents |
| Q61912328 | Cerebrospinal fluid transcriptional analyses reveals upregulation of IL-17, Type 1 interferon transcriptional pathways and neutrophil persistence genes associated with increased mortality from pneumococcal meningitis in adults: |
| Q40103299 | Cerebrovascular Complications of Pediatric Pneumococcal Meningitis in the PCV13 Era. |
| Q40328212 | Cervicomedullary injury after pneumococcal meningitis with brain edema |
| Q28277609 | Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States |
| Q34210804 | Characterization of a pneumococcal meningitis mouse model |
| Q93193476 | Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010-2018 |
| Q42334958 | Chemotherapeutic Studies in the Treatment of Meningococcal and Pneumococcal Meningitis |
| Q52149902 | Chiasmal optic neuritis may be secondary to pneumococcal meningitis: a child with acute monocular vision loss. |
| Q41716213 | Chickenpox complicated by pneumococcal meningitis: a rare coinfection. |
| Q48677693 | Circulating concentrations, cerebral output of the CINC-1 and blood–brain barrier disruption in Wistar rats after pneumococcal meningitis induction. |
| Q67598235 | Clinical contrasts in the presentation of pneumococcal meningitis |
| Q31023861 | Clinical data and factors associated with poor outcome in pneumococcal meningitis |
| Q38233731 | Clinical evaluation of pneumococcal meningitis in adults over a twelve-year period |
| Q53555333 | Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. |
| Q73114387 | Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations |
| Q34079508 | Clinical outcome of pneumococcal meningitis during the emergence of pencillin-resistant Streptococcus pneumoniae: an observational study |
| Q71504864 | Clinical path conference. Pneumococcal meningitis and brain abscess |
| Q43451814 | Clinical peculiarities of pneumococcal meningitis |
| Q40155020 | Clinical, biochemical and microbiological factors associated with the prognosis of pneumococcal meningitis in children |
| Q34214093 | Cognitive deficits following exposure to pneumococcal meningitis: an event-related potential study |
| Q77441656 | Coma in fulminant pneumococcal meningitis: new MRI observations |
| Q57253129 | Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis |
| Q46980766 | Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin-resistant strains |
| Q91803575 | Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage, and Hearing Loss in Infant Rat Pneumococcal Meningitis |
| Q39422232 | Comparative impact of pneumococcal conjugate vaccines on pneumococcal meningitis according to underlying conditions |
| Q44306067 | Comparative therapeutic efficacy of clinafloxacin in a pneumococcal meningitis mouse model |
| Q40774963 | Comparison of the clinical presentations of Naegleria fowleri primary amoebic meningoencephalitis with pneumococcal meningitis: a case-control study. |
| Q51388906 | Complicated pneumococcal meningitis in a fully vaccinated child: value of magnetic resonance imaging monitoring. |
| Q40206859 | Concurrent West Nile virus infection in pneumococcal meningitis: clinical and MRI features |
| Q58760149 | Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine |
| Q39305474 | Contribution of counter-immunoelectrophoresis (electro-immunodiffusion) to the diagnosis of pneumococcal meningitis (author's transl) |
| Q43881272 | Corticosteroid treatment of pneumococcal meningitis |
| Q73328464 | Corticosteroids in pneumococcal meningitis |
| Q72085965 | Counter current immunoelectrophoresis in the rapid diagnosis of pneumococcal meningitis |
| Q78671115 | Crystalline pancreatic desoxyribonuclease as an adjunct to the treatment of pneumococcal meningitis |
| Q44562803 | Current treatment of pneumococcal meningitis |
| Q68157146 | Current treatment of pneumococcal meningitis |
| Q80931042 | Cushing's triad in pneumococcal meningitis due to brainstem ischemia: early detection by diffusion-weighted MRI |
| Q53703330 | Cystic Encephalomalacia following Vasculopathy and Vasospasm of Proximal Intracranial Arteries Due to Pneumococcal Meningitis in a Infant. |
| Q62658686 | DECLINE IN PNEUMOCOCCAL MENINGITIS IN SPAIN AFTER INTRODUCTION OF THE HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE |
| Q58865279 | DELAYED CEREBRAL THROMBOSIS AFTER INITIAL GOOD RECOVERY FROM PNEUMOCOCCAL MENINGITIS: PAST AS PROLOGUE: DELAYED STROKE AS A PARAINFECTIOUS PROCESS OF BACTERIAL MENINGITIS? |
| Q46242792 | DNA repair protein APE1 is involved in host response during pneumococcal meningitis and its expression can be modulated by vitamin B6. |
| Q33437256 | Daptomycin in experimental murine pneumococcal meningitis |
| Q36155052 | Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France |
| Q90039472 | Declining Trends of Pneumococcal Meningitis in Gambian Children After the Introduction of Pneumococcal Conjugate Vaccines |
| Q96343311 | Delayed Cerebral Vasculopathy in Pneumococcal Meningitis: Epidemiology and Clinical Outcome. A Cohort Study |
| Q49334282 | Delayed cerebral thrombosis complicating pneumococcal meningitis: an autopsy study |
| Q38760560 | Depression-Like Adult Behaviors may be a Long-Term Result of Experimental Pneumococcal Meningitis in Wistar Rats Infants. |
| Q43440444 | Depressive seizure symptomatic of pneumococcal meningitis; therapeutic findings & effect of intraspinal hydrocortisone |
| Q30491013 | Detection of Significant Pneumococcal Meningitis Biomarkers by Ego Network |
| Q80130377 | Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study |
| Q43872663 | Development of hematogenous pneumococcal meningitis in adult mice: the role of TNF-alpha |
| Q54239109 | Development of pneumococcal meningitis during ceftriaxone therapy. |
| Q43802111 | Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats |
| Q63367710 | Dexamethasone and Pneumococcal Meningitis |
| Q80977946 | Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis |
| Q63367706 | Dexamethasone treatment in adults with pneumococcal meningitis: risk factors for death |
| Q69771836 | Diagnosis of pneumococcal meningitis by coagglutination method |
| Q92642418 | Diagnostic Yield of Pneumococcal Antigen Detection in Cerebrospinal Fluid for Diagnosis of Pneumococcal Meningitis Among Children in China |
| Q38513159 | Diagnostic and therapeutic aspects of pneumococcal meningitis in Africa (apropos of 119 cases) |
| Q40090718 | Diarrhea-associated pneumococcal meningitis with complicating hydrocephalus in a child in a resource-limited setting |
| Q35106470 | Differential effect of p47phox and gp91phox deficiency on the course of Pneumococcal Meningitis |
| Q64113777 | Diosmetin Suppresses Neuronal Apoptosis and Inflammation by Modulating the Phosphoinositide 3-Kinase (PI3K)/AKT/Nuclear Factor-κB (NF-κB) Signaling Pathway in a Rat Model of Pneumococcal Meningitis |
| Q91173641 | Double deficiency of toll-like receptors 2 and 4 alters long-term neurological sequelae in mice cured of pneumococcal meningitis |
| Q30540523 | Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis |
| Q104280455 | Drastic reduction in pneumococcal meningitis in children owing to the introduction of pneumococcal conjugate vaccines: Longitudinal analysis from 2002 to 2016 in Japan |
| Q54172213 | Drug-resistant pneumococcal meningitis in an American adult. |
| Q59647694 | Dual Phases of Apoptosis in Pneumococcal Meningitis |
| Q40560509 | Edaravone attenuates hippocampal damage in an infant mouse model of pneumococcal meningitis by reducing HMGB1 and iNOS expression via the Nrf2/HO-1 pathway |
| Q92812003 | Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016 |
| Q34463047 | Effect of experimental pneumococcal meningitis on respiration and circulation in the rabbit |
| Q34015633 | Effect of pneumococcal conjugate vaccine on pneumococcal meningitis |
| Q85892365 | Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in Children |
| Q48960734 | Effect of the bradykinin B2 receptor antagonist Hoe140 in experimental pneumococcal meningitis in the rat. |
| Q57253182 | Effects of Clinically Used Antioxidants in Experimental Pneumococcal Meningitis |
| Q30499261 | Effects of inner ear trauma on the risk of pneumococcal meningitis |
| Q74193193 | Effects of nimodipine on the cerebrovascular and neuronal changes during pneumococcal meningitis in the rat |
| Q33866540 | Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit |
| Q43178359 | Elevated cytokines in pneumococcal meningitis: Chicken or egg? |
| Q91233379 | Emergence of Ceftriaxone Resistance during a Case of Pneumococcal Meningitis with Fatal Evolution |
| Q32147558 | Endothelin B receptor-mediated increase of cerebral blood flow in experimental pneumococcal meningitis |
| Q57253180 | Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis |
| Q57253184 | Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis |
| Q40315147 | Enhanced diagnosis of pneumococcal meningitis with use of the Binax NOW immunochromatographic test of Streptococcus pneumoniae antigen: a multisite study |
| Q39305468 | Epidemiologic features of pneumococcal meningitis in Africa. Clinical and serotypical aspects (author's transl) |
| Q36188327 | Epidemiologic, clinical and bacteriologic characteristics of pneumococcal meningitis in pediatric patients from Lima, Peru |
| Q43933092 | Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso |
| Q38211919 | Epidemiology of pediatric pneumococcal meningitis and bacteremia in Latin America and the Caribbean: a systematic review and meta-analysis. |
| Q45904724 | Epidemiology of pneumococcal meningitis hospitalizations in pediatric population in Spain (1998-2006). |
| Q35407048 | Establishment of rat pneumococcal meningitis models: a histopathological analysis |
| Q46318829 | Estimating clinical and economic burden of pneumococcal meningitis in Malaysia using Casemix data. |
| Q57877601 | Evaluation of anti-pneumococcal capsular antibodies as adjunctive therapy in experimental pneumococcal meningitis |
| Q57611802 | Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis |
| Q100489185 | Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis |
| Q96764805 | Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination |
| Q67330710 | Experimental Pneumococcal Meningitis: III. Chemotactic Activity in Cerebrospinal Fluid |
| Q48554718 | Experimental pneumococcal meningitis I: a rabbit model. |
| Q41841795 | Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kd heat shock protein |
| Q48960928 | Experimental pneumococcal meningitis in mice: a model of intranasal infection |
| Q45134686 | Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion |
| Q71683459 | Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide |
| Q40882957 | Experimental pneumococcal meningitis: impaired clearance of bacteria from the blood due to increased apoptosis in the spleen in Bcl-2-deficient mice |
| Q40183887 | Experimental pneumococcal meningitis: role of leukocytes in pathogenesis. |
| Q35013994 | Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis |
| Q40959568 | Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules. |
| Q43846413 | Factors which affect the prognosis of pneumococcal meningitis |
| Q59317506 | Faculty of 1000 evaluation for Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis |
| Q59317509 | Faculty of 1000 evaluation for Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis |
| Q28344490 | Failure To detect muramic acid in normal rat tissues but detection in cerebrospinal fluids from patients with Pneumococcal meningitis |
| Q54169378 | Failure of Cefotaxime Treatment in a Patient with Penicillin-Resistant Pneumococcal Meningitis and Confirmation of Nosocomial Spread by Random Amplified Polymorphic DNA Analysis |
| Q55387061 | Fatal Cerebellar Hemorrhage Complicating Pneumococcal Meningitis: Are Anticoagulants the Hidden Enemy? |
| Q40215728 | Fatal pneumococcal meningitis in a 7-year-old girl with interleukin-1 receptor activated kinase deficiency (IRAK-4) despite prophylactic antibiotic and IgG responses to Streptococcus pneumoniae vaccines. |
| Q69476419 | Fatal pneumococcal meningitis in a colony-born monkey (Macaca fascicularis) |
| Q39961195 | Fatal pneumococcal meningitis in adults following splenectomy: two case reports and a review of the literature |
| Q64941976 | Fatal pneumococcal meningitis in an HIV-infected drug user despite previous pneumococcal immunization. |
| Q51899793 | Fatal pneumococcal meningitis: failure of acute care focus of medical practice. |
| Q38039435 | First Report of a Case of Pneumococcal Meningitis Which Did Not Respond to the Ceftriaxone Therapy despite the Isolated Organism Being Sensitive to This Antibiotic In Vitro. |
| Q56969548 | Focoidin, a polysaccharide inhibiting leukocyte rolling, attenuates inflammatory responses in experimental pneumococcal meningitis in rats |
| Q82147314 | Fractured base of skull complicated by pneumococcal meningitis |
| Q72947079 | Fulminant infection in a splenectomized patient with Hodgkin disease. Fatal pneumococcal meningitis in a cured patient seven years after splenectomy |
| Q83173917 | Fulminant pneumococcal meningitis manifesting as acute abdomen |
| Q39473262 | Gemifloxacin is effective in experimental pneumococcal meningitis |
| Q57253160 | Gene and protein expression of galectin-3 and galectin-9 in experimental pneumococcal meningitis |
| Q30817171 | Gene expression in cortex and hippocampus during acute pneumococcal meningitis |
| Q36538750 | Genetic Variation in NFKBIE Is Associated With Increased Risk of Pneumococcal Meningitis in Children |
| Q34761271 | Genetic variation and cerebrospinal fluid levels of mannose binding lectin in pneumococcal meningitis patients |
| Q96305718 | HIF-1α is involved in blood-brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis |
| Q48487982 | Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes. |
| Q48610449 | Hearing loss and pneumococcal meningitis: an animal model |
| Q50432840 | Hearing loss in adults surviving pneumococcal meningitis is associated with otitis and pneumococcal serotype. |
| Q48610366 | Hematogenous Pneumococcal Meningitis in the Infant Rat: Description of a Model |
| Q33494666 | Hemolytic-uremic syndrome in pneumococcal meningitis and infection. Importance of T-transformation |
| Q24811406 | High carriage rate of high-level penicillin-resistant Streptococcus pneumoniae in a Taiwan kindergarten associated with a case of pneumococcal meningitis |
| Q71655440 | Histochemical demonstration of neuraminidase effects in pneumococcal meningitis |
| Q33381656 | Identification of serotype in culture negative pneumococcal meningitis using sequential multiplex PCR: implication for surveillance and vaccine design |
| Q48023758 | Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats. |
| Q77126991 | Immunodiagnosis of pneumococcal meningitis using Dot-enzyme-linked immunosorbent assay |
| Q41247311 | Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil |
| Q91036575 | Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017 |
| Q38677563 | Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children |
| Q31141776 | Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis |
| Q36229752 | Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis. |
| Q40942223 | Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children |
| Q41076523 | Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children. |
| Q42114797 | Improving the outcome of pneumococcal meningitis |
| Q44897635 | In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-alpha converting enzyme attenuates seizures and injury of the cerebral cortex |
| Q92251987 | In vivo proteomics identifies the competence regulon and AliB oligopeptide transporter as pathogenic factors in pneumococcal meningitis |
| Q31142710 | In vivo study of experimental pneumococcal meningitis using magnetic resonance imaging |
| Q81093147 | Incessant monomorphic ventricular tachycardia associated with pneumococcal meningitis: a case report |
| Q36245375 | Incidence and outcome of pneumococcal meningitis in northern England |
| Q57165215 | Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey |
| Q43931792 | Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo |
| Q30828237 | Increase in hippocampal water diffusion and volume during experimental pneumococcal meningitis is aggravated by bacteremia |
| Q46729570 | Increased expression of tyrosine phosphatase SHP2 in experimental pneumococcal meningitis: correlation with tumor necrosis factor-alpha and cerebrospinal fluid pleocytosis |
| Q45364601 | Increased risk of death in human immunodeficiency virus-infected children with pneumococcal meningitis in South Africa, 2003-2005. |
| Q48363903 | Induction of haem oxygenase-1 causes cortical non-haem iron increase in experimental pneumococcal meningitis: evidence that concomitant ferritin up-regulation prevents iron-induced oxidative damage |
| Q46012219 | Induction of labyrinthitis ossificans after pneumococcal meningitis: an animal model. |
| Q27303066 | Infection of zebrafish embryos with live fluorescent Streptococcus pneumoniae as a real-time pneumococcal meningitis model. |
| Q39818938 | Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits |
| Q37029117 | Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits |
| Q73496212 | Inhibition of glutamine synthetase in rabbit pneumococcal meningitis is associated with neuronal apoptosis in the dentate gyrus |
| Q39515932 | Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits |
| Q50355978 | Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats |
| Q40373506 | Insidious presentation of pediatric pneumococcal meningitis: alive and well in the post vaccine era. |
| Q84941115 | Internal Hydrocephalus complicating Pneumococcal Meningitis Treated with Penicillin after Sulphonamides |
| Q89392689 | Intracranial mycotic aneurysm in a 5 month-old infant with pneumococcal meningitis |
| Q73332896 | Intraoperative intracranial pressure monitoring in pneumococcal meningitis |
| Q71709645 | Involvement of substance P in pial arteriolar vasodilatation during pneumococcal meningitis in the rat |
| Q38466769 | Is adjunctive corticosteroid beneficial in pneumococcal meningitis in a region with high rates of resistance to penicillin and ceftriaxone? |
| Q37087341 | JNK is activated but does not mediate hippocampal neuronal apoptosis in experimental neonatal pneumococcal meningitis |
| Q63367645 | Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis |
| Q64054865 | Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis |
| Q42792740 | LOCAL SPECIFIC THERAPY OF EXPERIMENTAL PNEUMOCOCCAL MENINGITIS : I. EXPERIMENTAL PNEUMOCOCCAL MENINGITIS IN RABBITS. |
| Q36253018 | LOCAL SPECIFIC THERAPY OF EXPERIMENTAL PNEUMOCOCCAL MENINGITIS : II. THE PRODUCTION, PATHOLOGY, AND TREATMENT OF TYPE I PNEUMOCOCCAL MENINGITIS IN DOGS. |
| Q41952487 | LOCAL SPECIFIC THERAPY OF EXPERIMENTAL PNEUMOCOCCAL MENINGITIS : III. INCIDENTAL MYELITIS, ABSCESS, AND ORGANIZATION OF EXUDATES. |
| Q36253194 | LOCAL SPECIFIC THERAPY OF EXPERIMENTAL PNEUMOCOCCAL MENINGITIS : IV. TYPE II PNEUMOCOCCAL MENINGITIS IN DOGS. |
| Q50546667 | Labyrinthitis ossificans after pneumococcal meningitis |
| Q81382808 | Late-onset rhabdomyolysis in pneumococcal meningitis: a case report |
| Q89178922 | Lesson Learned Through a Case of Pneumococcal Meningitis: Sometimes Doing Less Is More Harmful |
| Q31156447 | Leukocyte attraction by CCL20 and its receptor CCR6 in humans and mice with pneumococcal meningitis |
| Q45137731 | Leukoencephalopathy in pneumococcal meningitis: a diagnostic pitfall and treatment challenge |
| Q79436937 | Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study |
| Q48109507 | Limited efficacy of adjuvant therapy with dexamethasone in preventing hearing loss due to experimental pneumococcal meningitis in the infant rat. |
| Q64133061 | Linezolid as rescue therapy for pneumococcal meningitis |
| Q82432703 | Long-term beneficial effects of dexamethasone on intellectual and neuropsychological outcome of children with pneumococcal meningitis |
| Q46761728 | Long-term mortality in patients diagnosed with pneumococcal meningitis: a Danish nationwide cohort study |
| Q89478814 | Long-term neurologic and cognitive outcome and quality of life in adults after pneumococcal meningitis |
| Q46062619 | Long-term outcomes of pneumococcal meningitis in childhood and adolescence |
| Q44366341 | Long-term sequelae of pneumococcal meningitis in children |
| Q93156525 | Low-cerebrospinal fluid white cell counts and mortality in HIV-associated pneumococcal meningitis |
| Q73100554 | Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone |
| Q94001870 | M & B 693 in Pneumococcal Meningitis |
| Q36832315 | Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat. |
| Q33745901 | Mannose-binding lectin-deficient genotypes as a risk factor of pneumococcal meningitis in infants |
| Q33568104 | Mass spectrometry: pneumococcal meningitis verified and Brucella species identified in less than half an hour |
| Q44419517 | Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway |
| Q78863243 | Mechanism of Hypoglycorrhachia in Experimental Pneumococcal Meningitis |
| Q100544453 | Meningococcal and Pneumococcal meningitis in the ICU: an epidemiological report from the Italian GiViTI registry |
| Q92221531 | Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis |
| Q24803416 | Method for inducing experimental pneumococcal meningitis in outbred mice |
| Q67678187 | Mixed tuberculous and pneumococcal meningitis after splenectomy (author's transl) |
| Q71731828 | Molecular epidemiological characteristics of pneumococcal meningitis in children |
| Q36525328 | Molecular epidemiological investigation to determine the source of a fatal case of serotype 22F pneumococcal meningitis |
| Q59647767 | Molecular mechanisms of inflammation in experimental pneumococcal meningitis |
| Q59647768 | Molecular mechanisms of inflammation in experimental pneumococcal meningitis |
| Q92508742 | Molecular studies of meningococcal and pneumococcal meningitis patients in Ethiopia |
| Q43698357 | Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in England |
| Q66706721 | Mortality from pneumococcal meningitis |
| Q44166366 | Mortality in pneumococcal meningitis: a multivariate analysis of prognostic factors. |
| Q42241320 | Mortality indicators in pneumococcal meningitis: therapeutic implications |
| Q36882273 | Myeloid Src kinases regulate phagocytosis and oxidative burst in pneumococcal meningitis by activating NADPH oxidase |
| Q91720959 | Myeloid-Related Protein 8/14 Participates in the Progression of Experimental Pneumococcal Meningitis by Augmentation of Inflammation |
| Q89937144 | NOD2 regulates microglial inflammation through the TAK1-NF-κB pathway and autophagy activation in murine pneumococcal meningitis |
| Q46751547 | Near-infrared spectroscopy in experimental pneumococcal meningitis in the rabbit: cerebral hemodynamics and metabolism |
| Q44487941 | Neurodevelopmental sequelae in pneumococcal meningitis cases in Bangladesh: a comprehensive follow-up study |
| Q71809315 | Neurogenic Pulmonary Edema Associated with Pneumococcal Meningitis |
| Q64060577 | Neutrophil extracellular traps in the central nervous system hinder bacterial clearance during pneumococcal meningitis |
| Q89593636 | New Strategy Is Needed to Prevent Pneumococcal Meningitis |
| Q90043343 | New Virulence Factors Identified in Pneumococcal Meningitis |
| Q39833922 | New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits |
| Q59647757 | New insight on the pathogenesis and treatment of pneumococcal meningitis |
| Q37091903 | New vaccines for the prevention of pneumococcal infections |
| Q46654641 | Noninvasive monitoring of pneumococcal meningitis and evaluation of treatment efficacy in an experimental mouse model. |
| Q57077294 | Nonsteroidal Anti-Inflammatory Agents in the Therapy for Experimental Pneumococcal Meningitis |
| Q42200638 | Observations on Pneumococcal Meningitis as a Complication of Kala-Azar |
| Q42340657 | Observations on Pneumococcal Meningitis as a Complication of Kala-Azar |
| Q72691863 | On the prognosis of pneumococcal meningitis |
| Q40074794 | Otogenic pneumococcal meningitis with pneumocephalus |
| Q50543201 | Otologic sequelae after pneumococcal meningitis: a survey of 164 consecutive cases with a follow-up of 94 survivors. |
| Q42515037 | Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study |
| Q58777694 | Outbreak of Pneumococcal Meningitis, Paoua Subprefecture, Central African Republic, 2016-2017 |
| Q33920289 | Outbreak of pneumonia in the setting of fatal pneumococcal meningitis among US Army trainees: potential role of Chlamydia pneumoniae infection |
| Q79279636 | Outcomes following pneumococcal meningitis: room for improvement remains expansive |
| Q36704087 | Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy? |
| Q57195098 | P234 Stroke in paediatric pneumococcal meningitis |
| Q50730148 | PNEUMOCOCCAL MENINGITIS IN PREGNANCY AND THE PUERPERIUM. |
| Q78247628 | PNEUMOCOCCAL MENINGITIS IN THE RABBIT AS A CHEMOTHERAPEUTIC MODEL |
| Q76870143 | PNEUMOCOCCAL MENINGITIS WITH PROFUSE CEREBROSPINAL FLUID FLOW AFTER PLATINOFISSURE |
| Q76577141 | PNEUMOCOCCAL MENINGITIS, ITS CLINICAL PICTURE AND THERAPY AT AN INFECTIOUS DISEASE HOSPITAL DURING 1951-1961 |
| Q35464630 | PNEUMOCOCCAL MENINGITIS: A CASE SIMULATING AN ACUTE ABDOMEN WITH A REVIEW OF THE PERTINENT LITERATURE |
| Q76116077 | PNEUMOCOCCAL meningitis treated without intrathecal therapy |
| Q63367680 | Pathogenesis and pathophysiology of pneumococcal meningitis |
| Q72364482 | Pathogenesis of meningitis. VIII. Cerebrospinal fluid and blood concentrations of methicillin, cephalothin, and cephaloridine in experimental pneumococcal meningitis |
| Q71482735 | Pathology of the ear in pneumococcal meningitis |
| Q72662585 | Pathomorphological changes in experimentally-induced pneumococcal meningitis in rabbits treated with prolonged-action sulfanilamides |
| Q35937456 | Patient outcome in adults with pneumococcal meningitis or bacteraemia admitted to QECH |
| Q44600812 | Peculiar course of pneumococcal meningitis |
| Q82058291 | Penicillin and heparin in the treatment of pneumococcal meningitis; case report |
| Q83355128 | Penicillin and sulphonamides used in the treatment of pneumococcal meningitis |
| Q46958620 | Penicillin resistant pneumococcal meningitis in Kenyatta National Hospital, Nairobi, Kenya |
| Q74597142 | Penicillin- and cephalosporin-resistant pneumococcal meningitis: the future is now. The Infection and Immunisation Committee, New Zealand Paediatric Society |
| Q66860303 | Penicillin-resistant pneumococcal meningitis |
| Q67515196 | Penicillin-resistant pneumococcal meningitis |
| Q67517719 | Penicillin-resistant pneumococcal meningitis |
| Q73818379 | Penicillin-resistant pneumococcal meningitis |
| Q54149856 | Penicillin-resistant pneumococcal meningitis in Israel. |
| Q54286666 | Penicillin-resistant pneumococcal meningitis in an HIV-infected man. |
| Q54594914 | Penicillin-resistant pneumococcal meningitis in an immunocompromised infant |
| Q44795044 | Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection. |
| Q40745365 | Penicillin-resistant pneumococcal meningitis: report of two cases |
| Q62490440 | Peripheral blood RNA gene expression in children with pneumococcal meningitis: a prospective case-control study |
| Q35745699 | Persistence of pneumolysin in the cerebrospinal fluid of patients with pneumococcal meningitis is associated with mortality |
| Q79271956 | Persistent menace of pneumococcal meningitis |
| Q39785256 | Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis |
| Q33699541 | Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis |
| Q77925318 | Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitis |
| Q35640164 | Pharmacokinetics and bacteriological efficacies of apalcillin and cefpiramide in experimental pneumococcal meningitis |
| Q97526640 | Pneumocephalus Associated with Aggressive Pneumococcal Meningitis |
| Q53190416 | Pneumocephalus and pneumococcal meningitis after thoracic surgery. |
| Q83599274 | Pneumocephalus and pneumococcal meningitis secondary to a cerebrospinal fluid fistula |
| Q83381602 | PneumococcaL meningitis in french children before and after the introduction of pneumococcal conjugate vaccine |
| Q53188958 | Pneumococcal Meningitis Before and After Universal Vaccination With Pneumococcal Conjugate Vaccines 7/13, Impact on Pediatric Hospitalization in Public and Nonpublic Institutions, in Uruguay. |
| Q58551833 | Pneumococcal Meningitis Complicated by Cerebral Vasculitis, Abscess, Hydrocephalus, and Hearing Loss |
| Q96953292 | Pneumococcal Meningitis Complicated by Spinal Cord Dysfunction and Acute Polyradiculopathy |
| Q100302020 | Pneumococcal Meningitis Complicated by Subarachnoid Hemorrhage and Tonsillar Herniation |
| Q70785108 | Pneumococcal Meningitis Despite Chloramphenicol Prophylaxis |
| Q41182914 | Pneumococcal Meningitis Refractory to M & B 693. |
| Q84941265 | Pneumococcal Meningitis Treated by Penicillin |
| Q41580178 | Pneumococcal Meningitis Vaccine Breakthroughs and Failures After Routine 7-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Children in France |
| Q45049667 | Pneumococcal Meningitis and Endocarditis: A Case Report. |
| Q100731181 | Pneumococcal Meningitis and Its Sequelae - A Devastating CNS Disease |
| Q60313538 | Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009-June 2015 |
| Q29396242 | Pneumococcal Meningitis in Sickle-Cell Anemia |
| Q87341904 | Pneumococcal Meningitis in the PCV13 Era: A Cluster of Cases With Increased Morbidity and Mortality |
| Q93957549 | Pneumococcal Meningitis successfully treated with Sulphapyridine |
| Q54918426 | Pneumococcal Meningitis treated successfully with Sulphathiazole |
| Q71017136 | Pneumococcal Meningitis with a Prolonged Course in a Splenectomized Patient |
| Q78569801 | Pneumococcal Meningitis. Mastoidectomy Adjunctive to Antibiotic Treatment |
| Q57169790 | Pneumococcal Meningitis: A Clinical and Laboratory Study |
| Q50554492 | Pneumococcal meningitis and bacteraemia in Danish children 1969-1978. Serotypes, incidence and outcome. |
| Q40096448 | Pneumococcal meningitis and endocarditis in an infant: possible improved survival with factor V Leiden mutation |
| Q69169505 | Pneumococcal meningitis and endophthalmitis in a newborn |
| Q39136149 | Pneumococcal meningitis and etanercept--chance or association? |
| Q46839912 | Pneumococcal meningitis and otitis media |
| Q93792307 | Pneumococcal meningitis and peritonitis in rhesus monkeys |
| Q33185553 | Pneumococcal meningitis and resistant bacteria |
| Q68295919 | Pneumococcal meningitis and sepsis |
| Q35105368 | Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany |
| Q70486814 | Pneumococcal meningitis associated with retroperitoneal abscess. A rare complication of lumbar puncture |
| Q71069297 | Pneumococcal meningitis at Harlem hospital |
| Q91027637 | Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland |
| Q34652803 | Pneumococcal meningitis causes accumulation of neurotoxic kynurenine metabolites in brain regions prone to injury |
| Q70029349 | Pneumococcal meningitis complicated by immune complex-mediated arthritis |
| Q33502205 | Pneumococcal meningitis complicated with hemolytic uremic syndrome: report of two cases. |
| Q42921180 | Pneumococcal meningitis developing during chloramphenicol treatment. |
| Q54104568 | Pneumococcal meningitis due to psoas abscess. |
| Q46352007 | Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - do not miss vaccination before starting therapy. |
| Q67905328 | Pneumococcal meningitis during ciprofloxacin therapy for otitis media |
| Q68779325 | Pneumococcal meningitis during intravenous ciprofloxacin therapy |
| Q35753027 | Pneumococcal meningitis during pregnancy: a case report and review of literature |
| Q46973824 | Pneumococcal meningitis during therapy of otitis media with clarithromycin. |
| Q43933087 | Pneumococcal meningitis epidemics in Africa |
| Q45258207 | Pneumococcal meningitis following head injury |
| Q71091540 | Pneumococcal meningitis following intrathecal injections |
| Q70471766 | Pneumococcal meningitis following parenteral alimentation in infants |
| Q43878921 | Pneumococcal meningitis following routine immunisation |
| Q38894564 | Pneumococcal meningitis in Cantabria (Spain) in the pneumococcal conjugate vaccine era (2001-2015). |
| Q43003434 | Pneumococcal meningitis in Jamaican children. |
| Q81780755 | Pneumococcal meningitis in Taiwanese children: emphasis on clinical outcomes and prognostic factors |
| Q39697067 | Pneumococcal meningitis in Western Australian children: epidemiology, microbiology and outcome |
| Q61867717 | Pneumococcal meningitis in a child with a ventriculo-peritoneal shunt |
| Q46345112 | Pneumococcal meningitis in a patient with IL-1 receptor-associated kinase-4 deficiency: a case of failed prophylaxis |
| Q46691876 | Pneumococcal meningitis in a pediatric intensive care unit: prognostic factors in a series of 49 children |
| Q40213436 | Pneumococcal meningitis in a pregnant woman |
| Q37328902 | Pneumococcal meningitis in a young adult female with common variable immunodeficiency |
| Q72229270 | Pneumococcal meningitis in adults |
| Q76145935 | Pneumococcal meningitis in adults |
| Q45118512 | Pneumococcal meningitis in adults: Spectrum of complications and prognostic factors in a series of 87 cases |
| Q33994224 | Pneumococcal meningitis in adults: new approaches to management and prevention |
| Q37057832 | Pneumococcal meningitis in an adolescent with fever and foot ache |
| Q84296513 | Pneumococcal meningitis in an immunized patient with a transsphenoidal canal |
| Q57218527 | Pneumococcal meningitis in an immunocompetent adult with a cochlear implant |
| Q79519186 | Pneumococcal meningitis in an infant of 8 days; recovery |
| Q40438916 | Pneumococcal meningitis in childhood: a longitudinal prospective study |
| Q41184799 | Pneumococcal meningitis in children |
| Q50425889 | Pneumococcal meningitis in children |
| Q44646128 | Pneumococcal meningitis in children |
| Q44705152 | Pneumococcal meningitis in children under 15 years of age in Misiones (Argentina). Sixteen year's epidemiological surveillance |
| Q40402514 | Pneumococcal meningitis in children--9 1/2-year-experience at Szent László Hospital, Budapest, Hungary |
| Q44675277 | Pneumococcal meningitis in children: clinical findings, most frequent serotypes and outcome |
| Q37422587 | Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah |
| Q50517440 | Pneumococcal meningitis in children: prognostic indicators and outcome. |
| Q40592295 | Pneumococcal meningitis in children: relationship of antibiotic resistance to clinical characteristics and outcomes |
| Q84950152 | Pneumococcal meningitis in cirrhotics: distinctive findings of presentation and outcome |
| Q38903192 | Pneumococcal meningitis in community is frequent after craniocerebral trauma and in alcohol abusers. |
| Q83328323 | Pneumococcal meningitis in infancy and childhood |
| Q39806014 | Pneumococcal meningitis in infants |
| Q36569222 | Pneumococcal meningitis in medical practice in Africa. Clinical and epidemiologic data in Upper Volta |
| Q44818856 | Pneumococcal meningitis in mother and neonate |
| Q44228162 | Pneumococcal meningitis in newborn and young infants |
| Q67244745 | Pneumococcal meningitis in patients with a major sickle hemoglobinopathy |
| Q71726595 | Pneumococcal meningitis in sickle cell disease in childhood |
| Q36504651 | Pneumococcal meningitis in the North East Thames Region UK: epidemiology and molecular analysis of isolates |
| Q79039746 | Pneumococcal meningitis in the adult. Clinical, therapeutic, and prognostic aspects in forty-three patients |
| Q41981146 | Pneumococcal meningitis in the elderly |
| Q46865400 | Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation |
| Q54269483 | Pneumococcal meningitis in the infantile population of Cantabria |
| Q43903092 | Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases |
| Q40314754 | Pneumococcal meningitis in the newborn period in a prevaccination era: a 10-year experience at a tertiary intensive care unit. |
| Q44090428 | Pneumococcal meningitis in the rat: evaluation of peroxynitrite scavengers for adjunctive therapy |
| Q48346613 | Pneumococcal meningitis induces apoptosis in recently postmitotic immature neurons in the dentate gyrus of neonatal rats |
| Q28385453 | Pneumococcal meningitis is promoted by single cocci expressing pilus adhesin RrgA |
| Q79278065 | Pneumococcal meningitis masquerading as subarachnoid haemorrhage |
| Q44437501 | Pneumococcal meningitis masquerading as subarachnoid haemorrhage. |
| Q44828237 | Pneumococcal meningitis mortality in children. Prognostic factors in a series of 73 cases |
| Q55560524 | Pneumococcal meningitis of refractory type treated by replacement of cerebrospinal fluid with penicillin. |
| Q55422823 | Pneumococcal meningitis outbreak and associated factors in six districts of Brong Ahafo region, Ghana, 2016 |
| Q95414952 | Pneumococcal meningitis outbreaks in sub-Saharan Africa |
| Q39619006 | Pneumococcal meningitis post cochlear implantation: development of an animal model in the guinea pig. |
| Q37802576 | Pneumococcal meningitis post-cochlear implantation: potential routes of infection and pathophysiology |
| Q37802580 | Pneumococcal meningitis post-cochlear implantation: preventative measures |
| Q40443871 | Pneumococcal meningitis presenting with a simple febrile seizure and negative blood-culture result |
| Q50606161 | Pneumococcal meningitis secondary to intra-sphenoidal encephalocoele. |
| Q84633414 | Pneumococcal meningitis still with us in the era of conjugate vaccines |
| Q30499227 | Pneumococcal meningitis threshold model: A potential tool to assess infectious risk of new or existing inner ear surgical interventions |
| Q74276040 | Pneumococcal meningitis treated with hydrocortisone, ACTH, and antibiotics |
| Q42138334 | Pneumococcal meningitis treated with penicillin and aureomycin. |
| Q44005886 | Pneumococcal meningitis treated without intrathecal chemotherapy. |
| Q49917565 | Pneumococcal meningitis trends after pneumococcal conjugate vaccine introduction in Colombia: an interrupted time-series analysis. |
| Q50352954 | Pneumococcal meningitis with accompanying severe hearing loss: 3D-FLAIR imaging of the inner ear and treatment |
| Q42340294 | Pneumococcal meningitis with atypical features |
| Q67384307 | Pneumococcal meningitis with complications |
| Q78716279 | Pneumococcal meningitis with esophagitis, abscess formation, and upper gastrointestinal hemorrhage |
| Q75606078 | Pneumococcal meningitis with hyperglycemia and development of subdural effusion; successful treatment with chloramphenicol |
| Q40053456 | Pneumococcal meningitis with normal cerebrospinal biochemistry and no pneumococci at microscopy, mimicking a stroke: a case report |
| Q74670643 | Pneumococcal meningitis with normal cerebrospinal fluid in an immunocompetent adult |
| Q93633617 | Pneumococcal meningitis with purpura |
| Q67765526 | Pneumococcal meningitis with severe cerebral involvment, 2 clinical recurrences and complete recovery |
| Q76076119 | Pneumococcal meningitis with subdural effusions |
| Q92099977 | Pneumococcal meningitis without pleocytosis in a patient infected with HIV-1 |
| Q37052804 | Pneumococcal meningitis, cerebral venous thrombosis, and cervical arterial dissection: a run of bad luck? |
| Q44164926 | Pneumococcal meningitis, endocarditis and rupture of the aortic valve: a case report. |
| Q88134641 | Pneumococcal meningitis: a 12 year experience in a children's hospital prior to the universal immunization with a conjugate vaccine |
| Q77745973 | Pneumococcal meningitis: a 2-year evaluation of the cefotaxime-vancomycin combination |
| Q82325358 | Pneumococcal meningitis: a 21st century perspective |
| Q46476062 | Pneumococcal meningitis: a clinical and laboratory study |
| Q47156368 | Pneumococcal meningitis: analysis of the cases admitted in the last year in the intensive care unit of the National Institute for Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest |
| Q48338863 | Pneumococcal meningitis: antibiotics essential but insufficient |
| Q39697064 | Pneumococcal meningitis: clinical course and resource use in Western Australian children |
| Q33745369 | Pneumococcal meningitis: clinical outcomes in a pre-vaccine era at a Dublin paediatric hospital, 1999–2007 |
| Q30489130 | Pneumococcal meningitis: clinical-pathological correlations (MeninGene-Path) |
| Q33824167 | Pneumococcal meningitis: current pathophysiologic concepts |
| Q30499331 | Pneumococcal meningitis: development of a new animal model |
| Q41753892 | Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine |
| Q49861344 | Pneumococcal meningitis: epidemiological, clinical and bacteriological characteristics |
| Q68771356 | Pneumococcal meningitis: the problem of the unseen cerebrospinal fluid leak |
| Q82144125 | Pneumococcal meningitis; a report of two cases which recovered with residual neuropsychiatric symptoms following treatment with penicillin |
| Q80623020 | Pneumococcal meningitis; a review |
| Q75737949 | Pneumococcal meningitis; a review of forty cases |
| Q55691967 | Pneumococcal meningitis; a short survey of 78 patients in the Bristol clinical area. |
| Q83309974 | Pneumococcal meningitis; a study of six cases |
| Q82058284 | Pneumococcal meningitis; a survey of 20 cases |
| Q82130671 | Pneumococcal meningitis; case reports |
| Q79455712 | Pneumococcal meningitis; clinico-pathologic conference |
| Q73185893 | Pneumococcal meningitis; skull defects as an aetiological factor |
| Q84135068 | Pneumococcal vaccine reduces the rates of pneumococcal meningitis in children |
| Q40335794 | Postpartum maternal pneumococcal meningitis complicated by endocarditis |
| Q38411438 | Predictive risk factors for Listeria monocytogenes meningitis compared to pneumococcal meningitis: a multicenter case-control study. |
| Q66934540 | Prednisolone in the treatment of pneumococcal meningitis |
| Q39613006 | Pretreatment with granulocyte colony-stimulating factor attenuates the inflammatory response but not the bacterial load in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits |
| Q45415309 | Prevention of Memory Impairment and Neurotrophic Factors Increased by Lithium in Wistar Rats Submitted to Pneumococcal Meningitis Model |
| Q28757559 | Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis |
| Q48334546 | Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac |
| Q72298804 | Prognostic Factors in Pneumococcal Meningitis |
| Q93026378 | Prognostic factors in pediatric pneumococcal meningitis patients in mainland China: a retrospective multicenter study |
| Q34588032 | Prognostic factors of pneumococcal meningitis. Retrospective study of 31 cases |
| Q84432600 | Progression of cerebrovascular lesions in pneumococcal meningitis |
| Q39109933 | Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin |
| Q50661248 | Protection of blood brain barrier integrity and modulation of inflammatory mediators during treatment of pneumococcal meningitis with daptomycin or ceftriaxone. |
| Q72351429 | Protective effect of a 21-aminosteroid during experimental pneumococcal meningitis |
| Q48758825 | Protective effect of the antioxidant N-acetyl-L-cysteine in pneumococcal meningitis in the rat. |
| Q30499329 | Protective effects of local administration of ciprofloxacin on the risk of pneumococcal meningitis after cochlear implantation |
| Q37248844 | Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival. |
| Q40495900 | Pyomyositis of the M. quadriceps femoris in an 8-month-old boy following pneumococcal meningitis |
| Q93622362 | Quadriplegia after pneumococcal meningitis |
| Q38372940 | Quantitative Proteomics of Cerebrospinal Fluid in Paediatric Pneumococcal Meningitis |
| Q39779290 | Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits |
| Q55291726 | RECOVERY FROM PNEUMOCOCCAL MENINGITIS: NOTES ON A CASE TREATED BY FELTON'S SERUM |
| Q76849574 | RECURRENT CASES OF PNEUMOCOCCAL MENINGITIS |
| Q78339599 | RECURRENT PNEUMOCOCCAL MENINGITIS AND PREGNANCY: REPORT OF A CASE |
| Q91138929 | Rapid Streptococcus Pneumonia Antigen Detection on Postmortem Urine in a Death Due to Pneumococcal Meningitis |
| Q51300316 | Rapid diagnosis of pneumococcal meningitis: implications for treatment and measuring disease burden. |
| Q34946168 | Rapid real-time PCR for determination of penicillin susceptibility in pneumococcal meningitis, including culture-negative cases |
| Q89766312 | Rapidly fatal pneumococcal meningitis following non-penetrating traumatic brain injury |
| Q43639910 | Reactive nitrogen species contribute to blood-labyrinth barrier disruption in suppurative labyrinthitis complicating experimental pneumococcal meningitis in the rat. |
| Q47556364 | Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana. |
| Q84564361 | Rebound in the incidence of pneumococcal meningitis in northern France: effect of serotype replacement |
| Q98949709 | Receptor for Advanced Glycation End Products (RAGE) Mediates Cognitive Impairment Triggered by Pneumococcal Meningitis |
| Q79276412 | Receptor-destroying enzyme in cerebrospinal fluid of a case of pneumococcal meningitis |
| Q102050501 | Recognition and Outcomes of Pneumococcal Meningitis in 2 Tertiary Pediatric Hospitals Since the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine |
| Q83249328 | Recovery following pneumonia complicated by hemiplegia and pneumococcal meningitis |
| Q94347896 | Recovery from Pneumococcal Meningitis |
| Q94348054 | Recovery from Pneumococcal Meningitis |
| Q42342600 | Recovery from Pneumococcal Meningitis Treated with M. & B. 693. |
| Q77577000 | Recurrence of pneumococcal meningitis due to primary spontaneous cerebrospinal fluid fistulas |
| Q92249001 | Recurrent Pneumococcal Meningitis Secondary to Nasoethmoidal Meningocele |
| Q92901335 | Recurrent Pneumococcal Meningitis in Children: A Multicenter Case-control Study |
| Q28333561 | Recurrent penicillin-resistant pneumococcal meningitis after chloramphenicol therapy |
| Q69423561 | Recurrent pneumococcal meningitis |
| Q33490069 | Recurrent pneumococcal meningitis after splenectomy |
| Q50357499 | Recurrent pneumococcal meningitis in a child with congenital common cavity malformation of the inner ear. |
| Q37864522 | Recurrent pneumococcal meningitis in a child with transethmoidal encephalocele: a case report and review of literature. |
| Q72340149 | Recurrent pneumococcal meningitis in a patient with transient IgG subclass deficiency |
| Q24797559 | Recurrent pneumococcal meningitis in a splenectomised HIV-infected patient |
| Q43606195 | Recurrent pneumococcal meningitis in homozygous C3 deficiency |
| Q79656993 | Recurrent pneumococcal meningitis in pregnancy. Case report |
| Q80359820 | Recurring pneumococcal meningitis |
| Q34194556 | Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response |
| Q74096418 | Reduction of intracranial pressure by nimodipine in experimental pneumococcal meningitis |
| Q40547752 | Refractory status epilepticus due to pneumococcal meningitis in an infant with congenital immunodeficiency |
| Q54633591 | Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G. |
| Q68441187 | Relatively penicillin-resistant pneumococcal meningitis in a Brazilian infant |
| Q63367671 | Repeated lumbar puncture in adults with pneumococcal meningitis: An observational study |
| Q99355873 | Repetitive transcranial magnetic stimulation activates glial cells and inhibits neurogenesis after pneumococcal meningitis |
| Q42354095 | Report of the Use of M. & B. 693 in Pneumonia, Pneumococcal Meningitis, and Pneumococcal Empyema, with Reports on Two Cases of Exfoliative Dermatitis and One of Agranulocytosis Due to M. & B. 693. |
| Q35220927 | Report of two cases of aseptic meningitis with persistence of pneumococcal cell wall components in cerebrospinal fluid after Pneumococcal meningitis |
| Q54216141 | Resistant pneumococcal meningitis revealing sickle cell anemia |
| Q92115640 | Resurgence of pneumococcal meningitis in Europe and Northern America |
| Q61933588 | Resveratrol Acts Anti-Inflammatory and Neuroprotective in an Infant Rat Model of Pneumococcal Meningitis by Modulating the Hippocampal miRNome |
| Q73481811 | Rifabutin for Experimental Pneumococcal Meningitis |
| Q46649772 | Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model |
| Q39866960 | Rifampin for therapy of experimental pneumococcal meningitis in rabbits |
| Q56211024 | Rising Incidence of Beta-Lactam Resistance among Pneumococci in Kuwait: Failure of Cefotaxime Therapy in Pneumococcal Meningitis |
| Q31161080 | Risk Factors in Children Older than 5 Years with Pneumococcal Meningitis: Data from a National Network |
| Q44119586 | Risk factor analysis for pneumococcal meningitis in adults with invasive pneumococcal infection |
| Q43916611 | Role of Caspase-1 in experimental pneumococcal meningitis: Evidence from pharmacologic Caspase inhibition and Caspase-1-deficient mice |
| Q104607359 | Role of astroglial Connexin 43 in pneumolysin cytotoxicity and during pneumococcal meningitis |
| Q36879959 | Role of oxidative stress in the pathophysiology of pneumococcal meningitis |
| Q37704497 | Role of purinergic signaling in experimental pneumococcal meningitis |
| Q45034393 | SULFAPYRIDAZINE IN PNEUMOCOCCAL MENINGITIS IN RABBITS |
| Q64105681 | Seasonal upsurge of pneumococcal meningitis in the Central African Republic |
| Q48183164 | Serotype 35B Pneumococcal Meningitis in an Infant: Effect of Conjugate Vaccines on Invasive Disease and Implications for Practice |
| Q81314806 | Serotype 6B pneumococcal meningitis in an immunocompetent infant immunized with heptavalent pneumococcal conjugated vaccine |
| Q46499211 | Serotype and pneumococcal meningitis in Nigerian children. |
| Q33627288 | Serotyping pneumococcal meningitis cases in the African meningitis belt by use of multiplex PCR with cerebrospinal fluid. |
| Q38541765 | Severe Sepsis due to Otogenic Pneumococcal Meningitis with Pneumocephalus without Meningeal Symptoms |
| Q70623578 | Severe atopic eczema, recurrent pneumococcal meningitis and recurrent eczema herpeticum |
| Q44007935 | Severe pneumococcal meningitis and ceftriaxone allergy |
| Q57002753 | Severe pneumococcal meningitis heralding a deep hypogammaglobulinaemia related to common variable immunodeficiency, at the age of 27 years |
| Q63367657 | Sex-based differences in pneumococcal serotype distribution in adults with pneumococcal meningitis |
| Q50658731 | Sickle cell disease, pneumococcal meningitis and paraplegia with recovery. |
| Q92149546 | Spatial analysis of pneumococcal meningitis in São Paulo in the pre- and post-immunization era |
| Q48694501 | Spatial memory and learning deficits after experimental pneumococcal meningitis in mice |
| Q41106145 | Sphenoid Sinusitis Complicated by Pneumococcal Meningitis and an Infectious Aneurysm in the Intracavernous Carotid Artery |
| Q69197633 | Spinal cord dysfunction with quadriplegia complicating pneumococcal meningitis |
| Q55488964 | Spontaneous ("erosive") cerebrospinal rhinorrhea, with pneumococcal meningitis from anterior optic glioma. Case report. |
| Q30452697 | Spontaneous pneumocephalus caused by pneumococcal meningitis |
| Q47161699 | Sporadic isolated congenital asplenia with fulminant pneumococcal meningitis: a case report and updated literature review |
| Q38984608 | Streptococcus pneumoniae meningitis complicated by an intramedullary abscess: a case report and review of the literature |
| Q57195018 | Stroke in paediatric pneumococcal meningitis: a cross-sectional population-based study |
| Q79462899 | Studies on the pathogenesis of meningitis. III. Relationship of phagocytosis to the fall in cerebrospinal fluid sugar in experimental pneumococcal meningitis |
| Q68722045 | Studies on the pathogenesis of meningitis. VI. Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis |
| Q93973862 | Successful Chemotherapy for Haemolytic Streptococcal Meningitis and Pneumococcal Meningitis in the Same Patient |
| Q73903509 | Successful meropenem treatment of multiply resistant pneumococcal meningitis |
| Q61841409 | Successful postmortem cesarean section in a case of fulminant pneumococcal meningitis |
| Q72662578 | Sulfadimethoxine (madribon) action in pneumococcal meningitis in rabbits |
| Q93974587 | Sulphapyridine for Pneumococcal Meningitis |
| Q70275267 | Superoxide dismutase inhibits brain oedema formation in experimental pneumococcal meningitis |
| Q42325572 | Surgically Cured, Relapsed Pneumococcal Meningitis Due to Bone Defects, Non-invasively Identified by Three-dimensional Multi-detector Computed Tomography |
| Q33788115 | Surveillance of impact of PCV-10 vaccine on pneumococcal meningitis in Mozambique, 2013 - 2015 |
| Q43963987 | Surveillance of pneumococcal meningitis among children in Sindh, southern Pakistan |
| Q76753819 | THE ROLE OF TOXEMIA AND OF NEURAL INJURY IN THE OUTCOME OF PNEUMOCOCCAL MENINGITIS |
| Q69732156 | Temporal Bone Findings in Pneumococcal Meningitis |
| Q26824508 | Tetraplegia revealing a severe pneumococcal meningomyelitis: about a case and literature review |
| Q72018090 | The Limited Role of Pneumolysin in the Pathogenesis of Pneumococcal Meningitis |
| Q28250608 | The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release |
| Q50355979 | The burden of pneumococcal meningitis in Austrian children between 2001 and 2008. |
| Q88814885 | The cerebral protective effect and mechanism of action of vitamin B6 adjuvant ceftriaxone in experimental pneumococcal meningitis |
| Q73452068 | The combined value of chemoprophylaxis and pneumococcal vaccine in the prevention of recurrent pneumococcal meningitis |
| Q71699337 | The descriptive epidemiology of pneumococcal meningitis in New York City |
| Q101118967 | The formyl peptide receptor agonist Ac2-26 alleviates neuroinflammation in a mouse model of pneumococcal meningitis |
| Q39259143 | The prognosis and treatment of pneumococcal meningitis in Africa. 402 cases (author's transl) |
| Q37740250 | The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis |
| Q57077299 | The role of complement in inflammation during experimental pneumococcal meningitis |
| Q35068100 | The treatment of pneumococcal meningitis |
| Q79455708 | The treatment of pneumococcal meningitis |
| Q80628313 | The treatment of pneumococcal meningitis |
| Q72991802 | The treatment of pneumococcal meningitis since the introduction of penicillin |
| Q82124115 | The treatment of pneumococcal meningitis with penicillin |
| Q49165819 | The treatment of pneumococcal meningitis without intrathecal penicillin |
| Q87097151 | The wider implications of normal cerebrospinal fluid cellularity in pneumococcal meningitis |
| Q33654490 | Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitis |
| Q47364603 | Therapeutic hypothermia and inhalation anesthesia in a patient with severe pneumococcal meningitis and secondary cardiac arrest. |
| Q72203036 | Therapy of penicillin-resistant pneumococcal meningitis |
| Q46485650 | Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. |
| Q30499070 | Threshold shift: effects of cochlear implantation on the risk of pneumococcal meningitis |
| Q30303956 | Time course of hearing loss in an animal model of pneumococcal meningitis |
| Q49162246 | Time-dependent behavioral recovery after pneumococcal meningitis in rats |
| Q57253124 | Transcriptomic and immunohistologic analysis of pathogenetic and regeneration processes in pneumococcal meningitis |
| Q36231513 | Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitis |
| Q40742234 | Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review |
| Q93973727 | Treatment of Pneumococcal Meningitis with Sulphapyridine |
| Q44952904 | Treatment of pneumococcal meningitis in adults |
| Q71613489 | Treatment of pneumococcal meningitis with cephaloridine |
| Q76032867 | Treatment of pneumococcal meningitis with large doses of penicillin; a series of twenty consecutive cases |
| Q79556733 | Treatment of pneumococcal meningitis with sulfadizine and intrathecal penicillin G with recovery |
| Q57878079 | Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally |
| Q47917014 | Trends in pneumococcal meningitis hospitalizations following the introduction of the 13-valent pneumococcal conjugate vaccine in the United States. |
| Q42205657 | Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France |
| Q80947099 | Two siblings with lethal pneumococcal meningitis in a family with a mutation in Interleukin-1 receptor-associated kinase 4 |
| Q38616396 | Type 19 Pneumococcal Meningitis: A Patient With 75-Year Clinical and Serologic Follow Up, With a Review of the Evolution of Therapy From Antiserum to Sulfonamides to Penicillin |
| Q46196490 | Ultrastructural damage to the organ of corti during acute experimental Escherichia coli and pneumococcal meningitis in guinea pigs |
| Q38541919 | Unusual exanthema combined with cerebral vasculitis in pneumococcal meningitis: a case report |
| Q27316930 | V-akt murine thymoma viral oncogene homolog 3 (AKT3) contributes to poor disease outcome in humans and mice with pneumococcal meningitis |
| Q84104155 | Vaccination for the prevention of pneumococcal meningitis |
| Q54542901 | Vancomycin therapy of experimental pneumococcal meningitis caused by penicillin-sensitive and resistant strains. |
| Q37221547 | Variation of 46 Innate Immune Genes Evaluated for their Contribution in Pneumococcal Meningitis Susceptibility and Outcome |
| Q90831301 | Vitamin B12 is neuroprotective in experimental pneumococcal meningitis through modulation of hippocampal DNA methylation |
| Q46186525 | Watery diarrhea with fever: consider the possibility of pneumococcal meningitis |
| Q40218684 | Zinc metalloproteinase ZmpC suppresses experimental pneumococcal meningitis by inhibiting bacterial invasion of central nervous systems. |
| Q54381123 | [A case of pneumococcal meningitis resistant to beta-lactam antibiotic treatment]. |
| Q96343862 | [A case of pneumococcal meningitis with reversible arterial stenosis] |
| Q69727402 | [A case surviving overwhelming postsplenectomy infection syndrome with pneumococcal meningitis developing 26 years after splenectomy] |
| Q91794930 | [A multicentric clinical study on clinical characteristics and drug sensitivity of children with pneumococcal meningitis in China] |
| Q74143333 | [Acute cerebrovascular accident associated with drepanocytosis complicated by pneumococcal meningitis in two children] |
| Q74622946 | [Acute renal insufficiency in pneumococcal meningitis & its treatment with artificial kidney] |
| Q71926786 | [Adult pneumococcal meningitis complicated by cerebral infarction: a case report] |
| Q72997416 | [Adult respiratory distress in hemolytic-uremic syndrome secondary to pneumococcal meningitis] |
| Q70444981 | [Ambiguous CT finding in a fulminant pneumococcal meningitis] |
| Q68758336 | [An autopsy case of acute monocytic leukemia with pneumococcal meningitis] |
| Q76244434 | [Antibiotic therapy of pneumococcal meningitis] |
| Q71952464 | [Apropos of the current therapy of meningococcal and pneumococcal meningitis in children] |
| Q71388369 | [Bacteremia, lumbar puncture and pneumococcal meningitis] |
| Q71483647 | [Bilateral and severe segmental stenosis of intracranial carotids and their branches in a 10 1/2 month old girl with a pneumococcal meningitis (author's transl)] |
| Q73202723 | [Bilateral cerebral infarctions by pneumococcal meningitis] |
| Q74702403 | [Bullous pneumonia & pneumococcal meningitis in an infant with a positive tuberculin skin reaction] |
| Q72861026 | [C2 deficiency discovered in pneumococcal meningitis] |
| Q73847274 | [Can pneumococcal meningitis sometimes be cured by a single intramuscular injection?] |
| Q81488330 | [Case of adult pneumococcal meningitis associated with multiple cerebral infarction] |
| Q73270168 | [Case of pneumococcal meningitis complicated by empyema of the cerebral ventricle in a 3 1/2-month-old infant] |
| Q70058479 | [Case of pneumococcal meningitis in a 3-month-old child] |
| Q75810626 | [Case of pneumococcal meningitis successfully treated with penicillin and sulfathiazole.] |
| Q84232110 | [Case report; the clinicopathological report of a 68-year-old woman of pneumococcal meningitis with diffuse stenosis of the cerebral arteries] |
| Q67988014 | [Cerebellar infarction in pneumococcal meningitis] |
| Q87272395 | [Cerebral vasculitis: A rare complication of pneumococcal meningitis] |
| Q69407869 | [Characteristics of the course of pneumococcal meningitis in children] |
| Q79597934 | [Cholesteatoma of the cauda equina following pneumococcal meningitis in a child.] |
| Q69450247 | [Clinico-pathogenetic characteristics of meningococcal and pneumococcal meningitis] |
| Q56556472 | [Commentary apropos of 126 cases of pneumococcal meningitis observed at Wagadugu Hospital (Upper Volta)] |
| Q81497178 | [Comments about diagnosis and treatment of pneumococcal meningitis] |
| Q72682947 | [Concentration of long-acting sulfanilamides in the blood and cerebrospinal fluid of intact rabbits and in experimentally induced pneumococcal meningitis] |
| Q53987070 | [Demonstration of a cerebrospinal fluid circulation disorder following pneumococcal meningitis using a new cisternography method (Indium 111)] |
| Q71192765 | [Development of pneumococcal meningitis while receiving piperacillin therapy] |
| Q68680069 | [Diagnosis of pneumococcal meningitis] |
| Q70591114 | [Electroencephalographic aspects and thiopental in 4 cases of severe pneumococcal meningitis in children] |
| Q93045806 | [Extra-ventricular drainage for the treatment of pneumococcal meningitis and hydrocephalus: a case report] |
| Q71197453 | [Failure of pneumococcal vaccine to prevent pneumococcal meningitis] |
| Q70023067 | [Fatal pneumococcal meningitis 10 years after splenectomy] |
| Q87438873 | [Fatal pneumococcal meningitis due to serotype 19 A: A preventable case?] |
| Q68916752 | [Fatal pneumococcal meningitis in a 1-year-old child with homozygous C2 deficiency] |
| Q79468801 | [Foreign body in the right nasal cavity (iron projectile) complicated to pneumococcal meningitis suppurating] |
| Q70613872 | [Fulminant pneumococcal meningitis 26 years after cranial fracture] |
| Q68141232 | [Hypophyseal abscess and cerebral arteritis in a fatal course of pneumococcal meningitis] |
| Q70741430 | [Infectious endocarditis in the course of pneumococcal meningitis: apropos of a case] |
| Q78111465 | [Labyrinth malformation manifesting as pneumococcal meningitis] |
| Q74169816 | [Meningococcal and pneumococcal meningitis treated at the Clinic for Infectious Diseases of Sarajevo] |
| Q69607940 | [Morphology of pneumococcal meningitis in adults] |
| Q71693013 | [Neonatal splenectomy and pneumococcal meningitis in an infant. Description of a case] |
| Q64985101 | [Neonatal type 1 pneumococcal meningitis and maternal septicemia]. |
| Q70152325 | [Neutrophilic leukocyte function in pneumococcal meningitis] |
| Q73272624 | [Nosocomial pneumococcal meningitis complicating herpes meningoencephalitis] |
| Q70957724 | [Pneumococcal meningitis (apropos of 42 cases: 1973-1980)] |
| Q70421340 | [Pneumococcal meningitis and ENT infections. Review of 100 cases (author's transl)] |
| Q79003219 | [Pneumococcal meningitis and acute otitis media] |
| Q54153505 | [Pneumococcal meningitis and third generations cephalosporins] |
| Q73117612 | [Pneumococcal meningitis and variable common immunodeficiency] |
| Q79878156 | [Pneumococcal meningitis as onset of Waldenström macroglobulinemia] |
| Q73222899 | [Pneumococcal meningitis due to traumatic cerebrospinal rhinorrhea; cure by terramycin and surgical therapy of the rhinorrhea] |
| Q71197527 | [Pneumococcal meningitis following lumbar puncture] |
| Q79748096 | [Pneumococcal meningitis following spinal anesthesia] |
| Q67878016 | [Pneumococcal meningitis from 1974 to 1984] |
| Q81771260 | [Pneumococcal meningitis in France: age and medical risk factors in children] |
| Q50709423 | [Pneumococcal meningitis in Spanish children: incidence, serotypes and antibiotic resistance. Prospective and multicentre study]. |
| Q71854224 | [Pneumococcal meningitis in Togo] |
| Q80543873 | [Pneumococcal meningitis in a child complicated by arterial thrombosis] |
| Q82839137 | [Pneumococcal meningitis in a child with ethmoidal meningocele] |
| Q69669413 | [Pneumococcal meningitis in adults. A study of 141 episodes] |
| Q73248465 | [Pneumococcal meningitis in an infant cured without neurologic or neurosurgical sequellae] |
| Q83443503 | [Pneumococcal meningitis in children in France: 832 cases from 2001 to 2007] |
| Q71416757 | [Pneumococcal meningitis in children: should probabilistic antibiotherapy of infectious meningitis be modified?] |
| Q70839318 | [Pneumococcal meningitis in children] |
| Q73123896 | [Pneumococcal meningitis in two day old premature infant; recovery] |
| Q69818049 | [Pneumococcal meningitis partially resistant to penicillin: presentation of 2 cases and review of the literature] |
| Q54562432 | [Pneumococcal meningitis partially resistant to penicillin] |
| Q70907819 | [Pneumococcal meningitis partially resistant to penicillin] |
| Q73074698 | [Pneumococcal meningitis resistant to penicillin and nosocomial transmission in pediatric hospitals confirmed by genomic analysis] |
| Q93579948 | [Pneumococcal meningitis resistant to penicillin, chloramphenicol and tetracycline] |
| Q71509403 | [Pneumococcal meningitis resistant to penicillin: epidemiology] |
| Q71481397 | [Pneumococcal meningitis revealing dysplasia of the bony labyrinth in an infant] |
| Q80632636 | [Pneumococcal meningitis with residual ophthalmoplegia] |
| Q51849593 | [Pneumococcal meningitis, long term consequences]. |
| Q78591181 | [Pneumococcal meningitis: an analysis of 121 adult patients, including 9 cases treated with massive dose of penicillin] |
| Q81531734 | [Pneumococcal meningitis: impact of heptavalent pneumococcal conjugate vaccine] |
| Q74412576 | [Posttraumatic pneumococcal meningitis] |
| Q74219486 | [Prevalence of pneumococcal meningitis in Spanish children] |
| Q50689921 | [Prevalence pneumococcal meningitis in Spanish children] |
| Q71232433 | [Prognosis and treatment of pneumococcal meningitis in infancy (apropos of 6 cases)] |
| Q71014435 | [Prognostic value of EEG in pneumococcal meningitis in children] |
| Q72202162 | [Protective effect of dexamethasone and phenytoin in the treatment of experimental pneumococcal meningitis] |
| Q53763798 | [Purulent pneumococcal meningitis with positive hemo-ovocultures. Clinical and physiopathological remarks on bacteremias developing during purulent meningitis] |
| Q78326557 | [Recurrent pneumococcal meningitis as result of unusual posterior frontal sinus fractures in apparently minimal injuries of the frontobasal skull.] |
| Q70053817 | [Recurrent pneumococcal meningitis associated with C3 deficiency] |
| Q78849697 | [Recurrent pneumococcal meningitis, Medico-surgical therapeutics.] |
| Q72893600 | [Recurring pneumococcal meningitis] |
| Q73603327 | [Relapse of pneumococcal meningitis in a 70 years old woman; cure by hibernation] |
| Q74305025 | [Relapsing form of pneumococcal meningitis] |
| Q54167149 | [Resistant pneumococcal meningitis revealing sickle cell anemia: efficacy of cefotaxime-vancomycin combination] |
| Q72644243 | [Results of the treatment of pneumococcal meningitis on the basis of clinical material] |
| Q76865079 | [SUCESSFUL TREATMENT OF A CASE OF PNEUMOCOCCAL MENINGITIS WITH LONG-TERM COMBINED THERAPY OF ANTIBIOTICS AND ADRENAL CORTEX HORMONES.] |
| Q71514255 | [School physical training following pneumococcal meningitis] |
| Q69950621 | [Serious infections in alcoholics. 1. Bacteremia, lobar pneumococcal pneumonia and pneumococcal meningitis in alcoholics 1974-1987] |
| Q51956087 | [Serotype 19F pneumococcal meningitis in an imunocompetent infant immunized with heptavalent pneumococcal conjugated vaccine Prevenar]. |
| Q73486983 | [Study of pneumococcal meningitis] |
| Q67973449 | [Suppurated pneumococcal meningitis in infants and children: complications and prognostic factors] |
| Q77147930 | [The activity of antibiotics in combination versus Streptococcus pneumoniae. Implications in the treatment of pneumococcal meningitis] |
| Q86322674 | [The aftermath of pneumococcal meningitis] |
| Q73409778 | [The further development of children treated for pneumococcal meningitis with comments on the chemotherapy of pneumococcal meningitis] |
| Q78408332 | [The heptavalent pneumococcal conjugate vaccine in a case of recurrent pneumococcal meningitis] |
| Q70731429 | [The treatment of pneumococcal meningitis] |
| Q71898622 | [Therapeutic consideration of pneumococcal meningitis resistant to cefotaxime. Letter] |
| Q73894205 | [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis] |
| Q76286829 | [Therapy of otogenic and rhinogenic pneumococcal meningitis] |
| Q75791445 | [Therapy of pneumococcal meningitis with maximum penicillin doses.] |
| Q73920264 | [Therapy of pneumococcal meningitis] |
| Q73918624 | [Three cases of pneumococcal meningitis] |
| Q54511055 | [Traumatic pneumococcal meningitis] |
| Q70828331 | [Treatment and outcome of pneumococcal meningitis in adults. Study of a recent series of 70 episodes] |
| Q78458523 | [Treatment of meningococcic & pneumococcal meningitis with oleandomycin.] |
| Q88098841 | [Treatment of pneumococcal meningitis in children in 2014. Position statement of the French Group for Pediatric Infectious Diseases] |
| Q85121574 | [Treatment of pneumococcal meningitis with dexamethasone] |
| Q54207078 | [Treatment of pneumococcal meningitis] |
| Q73262662 | [Treatment of pneumococcal meningitis] |
| Q76089986 | [Treatment of pneumococcal meningitis] |
| Q54236425 | [Treatment with imipenem-cilastatin in a girl with resistant pneumococcal meningitis] |
| Q70643078 | [Value of research on bacterial antigens by counterimmunoelectrophoresis in pneumococcal meningitis] |
| Q93639848 | [Various characteristics of pneumococcal meningitis] |
| Q71416745 | [What antibiotic combinations for pneumococcal meningitis in children in 1996?] |
| Meningite pneumococcica | wikipedia |
Search more.